Telix Pharmaceuticals (TLX) Current Taxes (2023 - 2025)

Telix Pharmaceuticals (TLX) has reported Current Taxes for 3 consecutive years, with $30.7 million the latest figure, recorded in Q4 2025.

• Quarterly Current Taxes fell 10.39% year-over-year to $30.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.7 million (down 10.39% YoY) and the FY2025 annual result came in at $30.7 million, up 2.18% from the prior year.
• Current Taxes declined to $30.7 million in Q4 2025 per TLX's latest filing, from $34.3 million in the prior quarter.
• Over the last five years, Current Taxes for TLX reached as high as $34.3 million in Q4 2024 and fell as low as $13.5 million in Q4 2023.
• A 3-year average of $26.2 million and a median of $30.7 million in 2025 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2024 — Current Taxes surged 153.48% — and 2025, when it fell 10.39%.
• Year by year, Current Taxes stood at $13.5 million in 2023, then soared by 153.48% to $34.3 million in 2024, then fell by 10.39% to $30.7 million in 2025.
• According to Business Quant data, Current Taxes over the past three periods registered $30.7 million, $34.3 million, and $13.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.